However, all of these studies were focused on the inhibition of JAK2; JAK2 specifically mediates cytokine signaling for red blood cells and platelets, and its inhibition causes anemia and low platelets [33, 34]. The gene discussed is JAK2; the disease is anemia (phenotype).